BiomeSense, Inc. is a Chicago-based company at the forefront of transforming our understanding and utilization of the human microbiome for improved health. Led by a team of visionary microbiome experts, they have developed innovative technology and created the first large-scale microbiome database, revolutionizing the field of precision medicine.
With their pioneering GutLabTM automated laboratory system and MetaBiomeTM bioinformatics platform, BiomeSense offers continuous, at-home tracking and analysis of the microbiome, providing valuable insights into human development, immunity, and nutrition. Their groundbreaking research has the potential to significantly impact the fight against various diseases, including infection, cardiovascular conditions, cancer, and even mental health disorders.
Generated from the website